Endocrine complications of high-dose therapy with stem cell transplantation

Pediatric Transplantation

Volumn 8, Issue SUPPL. 5, 2004, Pages 39-50

  Sanders, Jean E ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Fertility; Growth rates; Puberty; Thyroid function

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC AGENT; BUSULFAN; CARMUSTINE; CYCLOPHOSPHAMIDE; ESTROGEN; ETOPOSIDE; FLUDARABINE; IMMUNOSUPPRESSIVE AGENT; MELPHALAN; PROGESTERONE; THIOTEPA; THYROXINE;

ADULTHOOD; AGE; AMENORRHEA; AZOOSPERMIA; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CHILD; CHILD DEVELOPMENT; CHILD GROWTH; CHILDHOOD CANCER; CONFERENCE PAPER; CONGENITAL MALFORMATION; CONGENITAL NEVUS; DELAYED PUBERTY; DOSE RESPONSE; DRUG MEGADOSE; ENDOCRINE DISEASE; ENDOCRINE FUNCTION; FEMALE; FOLLOW UP; GONAD DYSFUNCTION; GROWTH RATE; HEART VENTRICLE SEPTUM DEFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HYPOTHYROIDISM; IMMUNOSUPPRESSIVE TREATMENT; LOW BIRTH WEIGHT; MALE; OLIGOSPERMIA; OVARY INSUFFICIENCY; PREMATURE LABOR; PREPUBERTY; RADIATION DOSE; SPONTANEOUS ABORTION; WHOLE BODY RADIATION;

ABNORMALITIES, MULTIPLE; ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; CHILD; ENDOCRINE SYSTEM DISEASES; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PREGNANCY; RADIOTHERAPY; TRANSPLANTATION CONDITIONING;

EID: 2942711764     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-2265.2004.00165.x     Document Type: Conference Paper

References (105)

1. LOWREY GJ. Growth and Development of Children, 8th edn. Chicago, IL: Year Book Medical Publishers, 1986.
2. FLEMING ID, BLACK TL, THOMPSON EI, PRATT C, RAO B, HUSTU O. Thyroid dysfunction and neoplasia in children receiving neck irradiation for cancer. Cancer 1985: 55: 1190-1194.
3. SANDERS JE, BUCKNER CD, SULLIVAN KM, et al. Growth and development after bone marrow transplantation. In: BUCKNER CD, GALE RP, LUCARELLI G, eds. Advances and Controversies in Thalassemia Therapy: Bone Marrow Transplantation and Other Approaches. New York: Alan R. Liss, Inc., 1989: pp. 375-382.
4. MANENTI F, GALIMBERTI M, LUCARELLI G, et al. Growth and endocrine function after bone marrow transplantation for thalassemia. In: BUCKNER CD, GALE RP, LUCARELLI G, eds. Advances and Controversies in Thalassemia Therapy: Bone Marrow Transplantation and Other Approaches. New York: Alan R. Liss, Inc., 1989: pp. 273-280.
5. URBAN C, SCHWINGSHANDL J, SLAVC I, et al. Endocrine function after bone marrow transplantation without the use of preparative total body irradiation. Bone Marrow Transplant 1988: 3: 291-296.
6. SANDERS JE, THE LONG-TERM FOLLOW-UP TEAM. Endocrine problems in children after bone marrow transplant for hematologic malignancies. Bone Marrow Transplant 1991: 8: 2-4.
7. MICHEL G, SOCIÉ G, GEBHARD F, et al. Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: The impact of conditioning regimen without total-body irradiation - a report from the Societe Francaise de Greffe de Moelle. J Clin Oncol 1997: 15: 2238-2246.
8. LEGAULT L, BONNY Y. Endocrine complications of bone marrow transplantation in children. Pediatr Transplant 1999: 3: 60-66.
9. COHEN A, ROVELLI R, ZECCA S, et al. Endocrine late effects in children who underwent bone marrow transplantation: Review (review). Bone Marrow Transplant 1998: 21(Suppl. 2): S64-S67.
10. KATSANIS E, SHAPIRO RS, ROBISON LL, HAAKE RJ, KIM T, PESCOVITZ OH. Thyroid dysfunction following bone marrow transplantation: Long-term follow-up of 80 pediatric patients. Bone Marrow Transplant 1990: 5: 335-340.
11. SKLAR CA, KIM TH, RAMSAY NKC. Thyroid dysfunction among long-term survivors of bone marrow transplantation. Am J Med 1982: 73: 688-694.
12. BORGSTROM B, BOLME P. Thyroid function in children after allogeneic bone marrow transplantation. Bone Marrow Transplant 1994: 13: 59-64.
13. BOULAD F, BROMLEY M, BLACK P, et al. Thyroid dysfunction following bone marrow transplantation using hyperfractionated radiation. Bone Marrow Transplant 1995: 15: 71-76.
14. HANCOCK SL, COX RS, MCDOUGALL R. Thyroid diseases after treatment of Hodgkin's disease. N Engl J Med 1991: 325: 599-606.
15. FERREBEE JW, THOMAS ED. Factors affecting the survival of transplanted tissues. Am J Med Sci 1958: 235: 369-386.
16. SHALET SM. Irradiation-induced growth failure. Clin Endocrinol Metab 1986: 15: 591-606.
17. SHALET SM, CLAYTON PE, PRICE DA. Growth and pituitary function in children treated for brain tumours or acute lymphoblastic leukaemia. Horm Res 1988: 30: 53-61.
18. SANDERS JE, BUCKNER CD, SULLIVAN KM, et al. Growth and development in children after bone marrow transplantation. Horm Res 1988: 30: 92-97.
19. COHEN A, ROVELLI A, BAKKER B, et al. Final height of patients who underwent bone marrow transplantation for hematological disorders during childhood: A study by the Working Party for Late Effects-EBMT. Blood 1999: 93: 4109-4115.
20. HASSAN M, OBERG G, EHRSSON H. Pharmacokinetic and metabolic studies of high-dose busulphan in adults. Eur J Clin Pharmacol 1989: 36: 525-530.
21. SPRUYT LL, GLENNIE MJ, BEYERS AD, WILLIAMS AF. Signal transduction by the CD2 antigen in T cells and natural killer cells: Requirement for expression of a functional T cell receptor or binding of antibody Fc to the Fc receptor, Fc gamma RIIIA (CD16). J Exp Med 1991: 174: 1407-1415.
22. DE SIMONE M, VERROTTI A, LUGHETTI L, et al. Final height of thalassemic patients who underwent bone marrow transplantation during childhood. Bone Marrow Transplant 2001: 28: 201-205.
23. WINGARD JR, PLOTNICK LP, FREEMER CS, et al. Growth in children after bone marrow transplantation: Busulfan plus cyclophosphamide versus cyclophosphamide plus total body irradiation. Blood 1992: 79: 1068-1073.
24. GIORGIANI G, BOZZOLA M, LOCATELLI F, et al. Role of busulfan and total body irradiation on growth of prepubertal children receiving bone marrow transplantation and results of treatment with recombinant human growth hormone. Blood 1995: 86: 825-831.
25. AFIFY Z, SHAW PJ, CLAVANO-HARDING A, COWELL CT. Growth and endocrine function in children with acute myeloid leukaemia after bone marrow transplantation using busulfan/cyclophosphamide. Bone Marrow Transplant 2000: 25: 1087-1092.
26. ADAN L, DE LANVERSIN ML, THALASSINOS C, SOUBERBIELLE JC, FISCHER A, BRAUNER R. Growth after bone marrow transplantation in young children conditioned with chemotherapy alone. Bone Marrow Transplant 1997: 19: 253-256.
27. HOVI L, RAJANTIE J, PERKKIÖ M, SAINIO K, SlPILÄ I, SIIMES MA. Growth failure and growth hormone deficiency in children after bone marrow transplantation for leukemia. Bone Marrow Transplant 1990: 5: 183-186.
28. SANDERS JE, PRITCHARD S, MAHONEY P, et al. Growth and development following marrow transplantation for leukemia. Blood 1986: 68: 1129-1135.
29. THOMAS BC, STANHOPE R, PLOWMAN PN, LEIPER AD. Growth following single fraction and fractionated total body irradiation for bone marrow transplantation. Eur J Pediatr 1993: 152: 888-892.
30. HUMA Z, BOULAD F, BLACK P, HELLER G, SKLAR CA. Growth in children after bone marrow transplantation for acute leukemia. Blood 1995: 86: 819-824.
31. THOMAS BC, STANHOPE R, PLOWMAN PN, LEIPER AD. Endocrine function following single fraction and fractionated total body irradiation for bone marrow transplantation in childhood. Acta Endocrinol 1993: 128: 508-512.
32. BOZZOLA M, GIORGIANI G, LOCATELLI F, et al. Growth in children after bone marrow transplantation. Horm Res 1993: 39: 122-126.
33. HOLM K, NYSOM K, RASMUSSEN MH, et al. Growth, growth hormone and final height after BMT. Possible recovery of irradiation-induced growth hormone insufficiency. Bone Marrow Transplant 1996: 18: 163-170.
34. COHEN A, ROVELLI A, VAN-LINT MT, et al. Final height of patients who underwent bone marrow transplantation during childhood. Arch Dis Child 1996: 74: 437-440.
35. CLEMENT-DEBOERS A, OOSTDIJK W, VAN WEEL-SIPMAN MH, VAN DEN BROECK J, WIT JM, VOSSEN JM. Final height and hormonal function after bone marrow transplantation in children. J Pediatr 1996: 129: 544-550.
36. BRAUNER R, ADAN L, SOUBERBIELLE JC, et al. Contribution of growth hormone deficiency to the growth failure that follows bone marrow transplantation. J Pediatr 1997: 130: 785-792.
37. BRAUNER R, FONTOURA M, ZUCKER JM, et al. Growth and growth hormone secretion after bone marrow transplantation. Arch Dis Child 1993: 68: 458-463.
38. SANDERS JE. Bone marrow transplantation in pediatric oncology. In: PIZZO PA, POPLACK DG, eds. Principles and Practice of Pediatric Oncology. Philadelphia, PA: Lippincott-Raven Publishers, 1997, pp. 357-373.
39. SANDERS J, FLOWERS M, SIADAK M, MCGUIRE T. Negative impact of prior central nervous system (CNS) irradiation on growth and neuropsychological function (NPsF) after total body irradiation (TBI) and bone marrow transplant (BMT). Blood 1994: 84(Suppl. 1): 250a (#986 abstract).
40. Joss E, ZUPPINGER K, SCHWARTZ HP, ROTEN H. Final height of patients with pituitary growth failure and changes in growth variables after long-term hormonal therapy. Pediatr Res 1983: 17: 676-679.
41. BOURGUIGNON J-P. Linear growth as a function of age at onset of puberty and sex steroid dosage: Therapeutic implications. Endocr Rev 1988: 9: 467-488.
42. OHLSSON C, BENGTSSON BA, ISAKSSON OG, ANDREASSEN TT, SLOOTWEG MC. Growth hormone and bone (review). Endocr Rev 1998: 19: 55-79.
43. BACHRACH LK. Acquisition of optimal bone mass in childhood and adolescence (review). Trends Endocrinol Metab 2001: 12: 22-28.
44. BILLER BMK. Efficacy of growth hormone-replacement therapy: Body composition and bone density. Endocrinologist 1998: 8(Suppl.1): 15S-21S.
45. BARONCELLI GI, BERTELLONI S, CECCARELLI C, CUPELLI D, SAGGESE G. Dynamics of bone turnover in children with GH deficiency treated with GH until final height. Eur J Endocrinol 2000: 142: 549-556.
46. HUI SL, SLEMENDA CW, JOHNSTON CC, JR. The contribution of bone loss to postmenopausal osteoporosis. Osteoporos Int 1990: 1: 30-34.
47. MAUSETH RS, KELLY BE, SANDERS JE. Bone mineral density (BMD) in pediatric marrow transplant patients. Pediatr Res 2001: 49(Part 2): 82A, #P1-488. (abstract).
48. SANDERS JE. Growth and development after hematopoietic cell transplantation. In: THOMAS ED, BLUME KG, FORMAN SJ, eds. Hematopoietic Cell Transplantation, 2nd edn. Malden, MA: Blackwell Science, Inc., 1999, pp. 764-775.
49. PAPADIMITRIOU A, URENA M, HAMILL G, STANHOPE R, LEIPER AD. Growth hormone treatment of growth failure secondary to total body irradiation and bone marrow transplantation. Arch Dis Child 1991: 66: 689-692.
50. BORGSTRÖM B, BOLME P. Growth and growth hormone in children after bone marrow transplantation. Horm Res 1988: 30: 98-100.
51. OGILVY-STUART AL, CLARK DJ, WALLACE WH, et al. Endocrine deficit after fractionated total body irradiation. Arch Dis Child 1992: 67: 1107-1110.
52. OLSHAN JS, WILLI SM, GRUCCIO D, MOSHANG T, Jr. Growth hormone function and treatment following bone marrow transplant for neuroblastoma. Bone Marrow Transplant 1993: 12: 381-385.
53. SHALET SM, TOOGOOD A, RAHIM A, BRENNAN BM. The diagnosis of growth hormone deficiency in children and adults (review). Endocr Rev 1998: 19: 203-223.
54. OGILVY-STUART AL, SHALET SM. Growth and puberty after growth hormone treatment after irradiation for brain tumours. Arch Dis Child 1995: 73: 141-146.
55. MACGILLIVRAY MH, BAPTISTA J, JOHANSON A. Outcome of a four-year randomized study of daily versus three times weekly somatropin treatment in prepubertal naive growth hormone-deficient children. Genentech Study Group. J Clin Endocrinol Metab 1996: 81: 1806-1809.
56. LOCHTE HL, Jr., KASAKURA S, KARETZKY M, FERREBEE JW, THOMAS ED. Infusion of marrow in the mouse and dog after Thio-TEPA. Blood 1963: 21: 424-428.
57. DAHLLÖF G, FORSBERG CM, BORGSTROM B. Changes in craniofacial development induced by growth hormone therapy in children treated with bone marrow transplantation. Acta Paediatr 1994: 83: 1165-1169.
58. DAHLLÖF G, KREKMANOVA L, KOPP S, BORGSTROM B, FORSBERG CM, RINGDEN O. Craniomandibular dysfunction in children treated with total-body irradiation and bone marrow transplantation. Acta Odontol Scand 1994: 52: 99-105.
59. ROSENBERG SW, KOLODNEY H, WONG GY, MURPHY ML. Altered dental root development in long-term survivors of pediatric acute lymphoblastic leukemia. Cancer 1987: 59: 1640-1648.
60. DAHLLÖF G, FORSBERG CM, RINGDEN O, et al. Facial growth and morphology in long-term survivors after bone marrow transplantation. Eur J Orthod 1989: 11: 332-340.
61. DA FONSECA MA. Long-term oral and craniofacial complications following pediatric bone marrow transplantation (review). Pediatr Dent 2000: 22: 57-62.
62. DAHLLÖF G, BARR M, BOLME P, et al. Disturbances in dental development after total body irradiation in bone marrow transplant recipients. Oral Surg Oral Med Oral Pathol 1988: 65: 41-44.
63. DAHLLÖF G, HEIMDAHL A, BOLME P, LÖNNQVlST B, RINGDÉN O. Oral condition in children treated with bone marrow transplantation. Bone Marrow Transplant 1988: 3: 43-51.
64. DAHLLÖF G, FORSBERG C-M, NÄSMAN M, et al. Craniofacial growth in bone marrow transplant recipients treated with growth hormone after total body irradiation. Scand J Dent Res 1991: 99: 44-47.
65. GREEN H, MORIKAWA M, NIXON T. A dual effector theory of growth-hormone action (review). Differentiation 1985: 29: 195-198.
66. CUTTER GB, CASSOSTA FG, ROSS JR. Pubertal growth: Physiology and pathophysiology. Recent Prog Horm Res 1986: 42: 443-470.
67. RAY H, MATTISON D. How radiation and chemotherapy affect gonadal function. Contemp Obstet Gynecol 1985: 109: 106-115.
68. SHALET SM, BEARDWELL CG, JACOBS HS, PEARSON D. Testicular function following irradiation of the human prepubertal testes. Clin Endocrinol 1978: 9: 483-490.
69. SANDERS JE, HAWLEY J, LEVY W, et al. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood 1996: 87: 3045-3052.
70. SANDERS JE, THE SEATTLE MARROW TRANSPLANT TEAM. The impact of marrow transplant preparative regimens on subsequent growth and development. Semin Hematol 1991: 28: 244-249.
71. TEINTURIER C, HARTMANN O, VALTEAU-COUANET D, BENHAMOU E, BOUGNERES PF. Ovarian function after autologous bone marrow transplantation in childhood: High-dose busulfan is a major cause of ovarian failure. Bone Marrow Transplant 1998: 22: 989-994.
72. ULDALL PR, KERR DNS, TACCHI D. Amenorrhea and sterility. Lancet 1972: i: 693-694.
73. BELOHORSKY B, SIRACKY J, SANDOR L, KLAUBER E. Comments on the development of amenorrhea caused by Myleran in cases of chronic myelosis. Neoplasia 1960: 4: 397-402.
74. WARNE GL, FAIRLEY KF, HOBBS JB, MARTIN FIR. Cyclophosphamide-induced ovarian failure. N Engl J Med 1973: 289: 1159-1162.
75. LUSHBAUGH CC, CASARETT GW. The effects of gonadal irradiation in clinical radiation therapy: A review. Cancer 1976: 37: 1111-1120.
76. KAY H, MATTISON D. How radiation and chemotherapy affect gonadal function. Contemp Obstet Gynecool 1985: 109: 106-115.
77. SHALET SM. Effects of cancer chemotherapy on gonadal function of patients. Cancer Treat Rev 1980: 7: 131-152.
78. ETTELDORF JN, WEST CD, PITCOCK JA, WILLIAMS DL. Gonadal function, testicular histology, and meiosis following cyclophosphamide therapy in patients with nephrotic syndrome. J Pediatr 1976: 88: 206-212.
79. FAIRLEY KF, BARRIE JU, JOHNSON W. Sterility and testicular atrophy related to cyclophosphamide therapy. Lancet 1972: i: 568-569.
80. SHAPIRO E, KINSELLA TJ, MAKUCH RW, et al. Effects of fractionated irradiation on endocrine aspects of testicular function. J Clin Oncol 1985: 3: 1232-1239.
81. SANDERS JE, BUCKNER CO, AMOS D, et al. Ovarian function following marrow transplantation for aplastic anemia or leukemia. J Clin Oncol 1988: 6: 813-818.
82. CARD RT, HOLMES IH, SUGARMAN RG, STORB R, THOMAS ED. Successful pregnancy after high dose chemotherapy and marrow transplantation for treatment of aplastic anemia. Exp Hematol 1980: 8: 57-60.
83. JACOBS P, DUBOVSKY DW. Bone marrow transplantation followed by normal pregnancy. Am J Hematol 1981: 11: 209-212.
84. DEEG HJ, KENNEDY MS, SANDERS JE, THOMAS ED, STORB R. Successful pregnancy after marrow transplantation for severe aplastic anemia and immunosuppression with cyclosporine. JAMA 1983: 250: 647
85. SCHMIDT H, EHNINGER G, DOPFER R, WALLER HD. Pregnancy after bone marrow transplantation for severe aplastic anemia. Bone Marrow Transplant 1987: 2: 329-332.
86. DEEG HJ, LEISENRING W, STORB R, et al. Long-term outcome after marrow transplantation for severe aplastic anemia. Blood 1998: 91: 3637-3645.
87. SALOOJA N, SZYDLO RM, SOCIE G, et al. Pregnancy outcomes after peripheral blood or bone marrow transplantation: A retrospective survey. Lancet 2001: 358: 271-276.
88. GRIGG AP, MCLACHLAN R, ZAJA J, SZER J. Reproductive status in long-term bone marrow transplant survivors receiving busulfan-cyclophosphamide (120 mg/kg). Bone Marrow Transplant 2000: 26: 1089-1095.
89. TURA S, MAZZA P, GHERLINZONI F, et al. High-dose therapy followed by autologous bone marrow transplantation (ABMT) in previously untreated non-Hodgkin's lymphoma. Scand J Haematol 1986: 37: 347-352.
90. RUSSELL JA, HANLEY DA. Full-term pregnancy after allogeneic transplantation for leukemia in a patient with oligomenorrhea. Bone Marrow Transplant 1989: 4: 579-580.
91. BUSKARD N, BALLEM P, HILL R, FRYER C. Normal fertility after total body irradiation and chemotherapy in conjunction with a bone marrow transplantation for acute leukemia. 15th Annual Meeting of the EBMT, Badgastein/Austria, February 26-March 2: 1989: p. 76 (abstract).
92. MILLIKEN S, POWLES R, PARIKH P, et al. Successful pregnancy following bone marrow transplantation for leukaemia. Bone Marrow Transplant 1990: 5: 135-137.
93. GIRI N, VOWELS MR, BARR AL, MAMEGHAN H. Successful pregnancy after total body irradiation and bone marrow transplantation for acute leukaemia. Bone Marrow Transplant 1992: 10: 93-95.
94. LIPTON JH, DERZKO C, FYLES G, MEHARCHAND J, MESSNER HA. Pregnancy after BMT: Three case reports. Bone Marrow Transplant 1993: 11: 415-418.
95. BARUCH J, BENJAMIN S, TRELEAVEN J, WILCOX AH, BARRON JL, POWLES R. Male Sexual function following bone marrow transplantation. Bone Marrow Transplant 1991: 7(Suppl. 2): 52.
96. SCHIMMER AD, ALI V, STEWART AK, IMRIE K, KEATING A. Male sexual function after autologous blood or marrow transplantation. Biol Blood Marrow Transplant 2001: 7: 279-283.
97. HARRIS E, MAHENDRA P, MCGARRIGLE HH, LINCH DC, CHATTERJEE R. Gynaecomastia with hypergonadotrophic hypogonadism and Leydig cell insufficiency in recipients of high-dose chemotherapy or chemo-radiotherapy. Bone Marrow Transplant 2001: 28: 1141-1144.
98. AISNER J, WIERNIK PH, PEARL P. Pregnancy outcome in patients treated for Hodgkin's disease. J Clin Oncol 1993: 11: 507-512.
99. MARDEN PM, SMITH DW, MCDONALD MJ. Congenital anomalies in the newborn infant, including minor variations. J Pediatr 1964: 64: 357-371.
100. DE SANCTIS V, GALIMBERTI M, LUCARELLI G, POLCHI P, RUGGIERO L, VULLO C. Gonadal function after allogeneic bone marrow transplantation for thalassaemia. Arch Dis Child 1991: 66: 517-520.
101. SHULL RM, BREIDER MA, CONSTANTOPOULOS GC. Long-term neurological effects of bone marrow transplantation in a canine lysosomal storage disease. Pediatr Res 1988: 24: 347-352.
102. SARAFOGLOU K, BOULAD F, GILLIO A, SKLAR C. Gonadal function after bone marrow transplantation for acute leukemia during childhood. J Pediatr 1997: 130: 210-216.
103. FANN JR, ROTH-ROEMER S, BURINGTON BE, KATON WJ, SYRJALA KL. Delirium in patients undergoing hematopoietic stem cell transplantation: Incidence and pre transplantation risk factors. Cancer 2002: 95: 1971-1981.
104. HINTERBERGER-FISCHER M, KIER P, KALHS P, et al. Fertility, pregnancies and offspring complications after bone marrow transplantation. Bone Marrow Transplant 1991: 7: 5-9.
105. CALMARD-ORIOL P, DAURIAC C, VU VAN H, LACROZE M, LANDRIOT B, GUVOTAT D. Successful pregnancy following allogeneic bone marrow transplantation after conditioning by thoraco-abdominal irradiation. Bone Marrow Transplant 1991: 8: 229-230.